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Essential role of the T cell–specifi  c adapter
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T cell–specifi  c adapter protein (TSAd) is a SRC-homology-2 (SH2) domain–containing 
intracellular signaling molecule that is required for T cell antigen receptor (TCR)–induced 
cytokine synthesis in T cells. How TSAd functions in TCR signal transduction is not clear. 
Previous work has suggested a nuclear role for this adapter. However, other evidence sug-
gests that TSAd also functions in the cytoplasm. Using T cells from TSAd-defi  cient mice, we 
now show that the major role of TSAd in the cytoplasm is in activation of the LCK protein 
tyrosine kinase at the outset of TCR signal transduction. Consequently, TSAd regulates 
several downstream signaling events, including intracellular calcium mobilization and 
activation of the Ras–extracellular signal–regulated kinase signaling pathway. TSAd regu-
lates LCK activity directly through physical interaction with LCK SH3 and SH2 domains. 
These studies reveal TSAd as a positive regulator of proximal TCR signal transduction and 
provide important new information on the mechanism of TCR-induced LCK activation.
TCR binding to antigen-MHC molecules 
  displayed on APCs triggers the activation of 
pro  tein tyrosine kinases (PTKs) (1). The fi  rst 
PTK to become activated is the SRC family 
PTK, LCK, which phosphorylates tyrosine 
residues in immunoreceptor tyrosine-based ac-
tivation motifs (ITAMs) present in TCR sig-
naling chains such as TCRζ. Phosphorylated 
ITAMS are recognized by SRC-homology-2 
(SH2) domains of the Syk-family PTK, ZAP-70, 
which is thus recruited to the complex and ac-
tivated, in part through transphosphorylation 
by LCK. In turn, activated ZAP-70 phosphor-
ylates the LAT transmembrane adaptor protein 
leading to SH2 domain–mediated interaction 
with diff   erent signaling molecules including 
phospholipase Cγ1 (PLCγ1), and the cyto-
solic adaptor proteins, Grb-2 and GADS. Re-
cruitment of these signaling molecules to the 
membrane triggers the activation of distinct 
signaling pathways that culminate in the activa-
tion of AP-1, ΝFκΒ, and NFAT transcription 
factors. Together, these transcription factors 
induce the expression of numerous genes that 
drive T cell proliferation and diff  erentiation into 
eff  ector cells.
T cell–specifi  c adaptor protein (TSAd) is a 
relatively recently described SH2 domain–con-
taining intracellular adaptor molecule that was 
initially reported to be restricted in expression 
to the T cell lineage (2, 3). TSAd appears to 
play an important role in TCR signal transduc-
tion as indicated by the fact that T cells from 
TSAd-defi  cient mice secrete reduced quan-
tities of the cytokines IL-2, IL-4, and IFN-γ in 
response to TCR engagement (4, 5). Exactly 
how TSAd participates in TCR signal trans-
duction is unknown. In previous studies, a role 
for TSAd as a direct regulator of cytokine gene 
transcription in the nucleus has been suggested 
(6). In addition, TSAd has been shown to in-
teract physically with diff  erent  cytoplasmic 
protein kinases, suggesting an important func-
tion in this cellular compartment as well (3, 4, 7). 
One such kinase that TSAd interacts with is 
LCK (3, 8). Physical interaction with LCK has 
been demonstrated in yeast–hybrid systems and 
T cell lines, although the functional signifi  cance 
of this interaction is not clearly understood. 
Under conditions of strong overexpression in 
T cell lines, TSAd can inhibit LCK activity 
(8, 9). However, the notion that TSAd, a posi-
tive regulator of T cell cytokine synthesis, acts 
as a physiological inhibitor of LCK is at odds 
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with the fact that LCK is   required for cytokine synthesis and 
other T cell responses (10).
In the present studies, we have used TSAd-defi  cient mice 
to further address the role of TSAd in the T cell cytoplasm. 
We report that TSAd controls multiple TCR-initiated cyto-
plasmic signaling pathways that can be explained on the basis 
that TSAd is in fact essential for the activation of LCK.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
We examined if TSAd is required for the activation of extra-
cellular signal–regulated kinase (ERK), c-Jun NH2-terminal 
protein kinase (JNK), and p38 kinases that regulate cytokine 
secretion through phosphorylation of AP-1 and other tran-
scription factors (11). LN T cells from TSAd (+/+) and 
(−/−) mice were stimulated with mAb against CD3ε (a 
component of the TCR complex) and the CD28 costimula-
tory receptor and kinase activation was assessed by Western 
blotting using phospho-specifi  c antibodies (Fig. 1 A). ERK1, 
ERK2, and p38 were activated weakly and with delayed 
kinetics in TSAd (−/−) compared with (+/+) T cells. 
  Activation of JNK was also impaired and delayed although 
to a lesser extent than ERKs and p38 (Fig. 1 A). As de-
termined in Raf-1–Ras-binding domain (RBD) pull-down 
assays,   activation of the Ras small G-protein was delayed in 
TSAd (−/−) T cells, which explains the blocked ERK re-
sponse (Fig. 1 B).
We also examined if TSAd was required for CD3/CD28-
induced intracellular calcium mobilization that is necessary 
for nuclear translocation of NFAT and cytokine gene tran-
scription (12). Calcium mobilization was monitored with the 
use of the Fura-2 calcium-sensitive fl  uorescent dye (Fig. 1 C).
Using relatively high concentrations of stimulating CD3 and 
CD28 mAb (optimal), only a small diff  erence in the calcium 
response between TSAd (−/−) and (+/+) T cells was noted. 
However, using 20-fold lower concentrations of mAb (sub-
optimal), TSAd (−/−) T cells showed a clear defective cal-
cium response.
Through its ability to generate InsP3 and DAG, which 
promotes recruitment of RasGRP1 to the plasma membrane, 
PLCγ1 lies upstream of calcium and Ras–ERK signaling 
pathways (12–14). We determined that PLCγ1 was not acti-
vated properly in TSAd (−/−) T cells (Fig. 2 A). This fi  nd-
ing, therefore, provides an explanation for the defective 
calcium and Ras–ERK responses. Activation of PLCγ1 in 
T cells is dependent on SH2 domain–mediated recruitment 
of PLCγ1 to phosphorylated Y136 of LAT (15, 16). In addi-
tion, Grb-2 binds to phosphorylated Y175, Y195, and Y235 
of LAT via its SH2 domain and in so doing contributes to the 
activation of Ras (15, 16). Therefore, we examined if LAT 
interacted with PLCγ1 and Grb-2 in TSAd (−/−) T cells 
(Fig. 2 B). As shown, reduced quantities of PLCγ1 and Grb-2 
were coimmunoprecipitated with LAT after CD3/CD28 
Figure 1.  Defective activation of ERK, JNK, and p38 kinases and 
impaired intracellular calcium mobilization in TSAd-defi  cient T cells. 
(A and B) LN T cells from TSAd (+/+) and TSAd (−/−) mice were stimu-
lated with optimal concentrations of CD3 and CD28 mAb for the indicated 
times (in min).  White lines indicate that intervening lanes have been 
spliced out. (A) ERK, JNK, and p38 activation was assessed by Western 
blotting of whole cell lysates using phospho-specifi  c antibodies. Relative 
densitometry scanning readings for phospho-JNK1 are indicated below 
the image. (B) Active GTP-bound Ras was pulled down from lysates of 
LN T cells with a Raf-1–RBD fusion protein and quantifi  ed by Western 
blotting using a Ras antibody. (C) Fura-2–loaded LN T cells were stimu-
lated with optimal or suboptimal concentrations of CD3 plus CD28 mAb 
at the indicated time point. Shown is the ratio (R) of light emission at a 
510-nm wavelength at excitation wavelengths of 340 and 380 nm over 
time. Ionomycin (Iono) was added to cells at the indicated point as a 
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  engagement and this correlated with reduced phosphoryla-
tion of LAT tyrosine residues Y136 and Y195, respectively. 
Because ZAP-70 is the principal PTK responsible for phos-
phorylation of LAT, we examined ZAP-70 activation in 
TSAd (−/−) T cells by Western blotting (Fig. 2 C). ZAP-70 
was indeed only weakly activated in response to CD3/
CD28 engagement.
ZAP-70 activation during TCR signal transduction is de-
pendent on kinases of the SRC family, particularly LCK (1). 
Consistent with the possibility that TSAd is required for the 
activation of LCK, bands corresponding to the molecular 
weight of SRC family kinases and the TCRζ chain were 
found to be hypophosphorylated in whole phosphotyrosine 
Western blots of CD3/CD28-stimulated TSAd (−/−) T cells 
(Fig. 3 A). After confi  rming that TSAd and LCK interact 
physically with another in wild-type LN T cells in response 
to CD3/CD28 engagement (Fig. 3 B), we examined LCK 
activation directly. As shown in both Western blotting ex-
periments and in vitro autokinase assays, LCK was activated 
poorly in TSAd (−/−) T cells in response to CD3/CD28 
(Fig. 3, C and D). Thus, in primary T cells, TSAd functions 
as a positive and not a negative regulator of LCK, consistent 
with the fi  nding that TSAd is required for normal induction 
of cytokines (4, 5). Most likely, previous reports of an inhibi-
tory eff  ect of TSAd upon LCK activation are an artifact of 
strong overexpression of TSAd and or/the use of the Jurkat 
leukemia cell line in experiments (8, 9). Indeed, under con-
ditions of mild overexpression, TSAd can augment IL-2 gene 
transcription in Jurkat (6). 
We examined if TSAd has the capacity to activate LCK 
kinase activity directly (Fig. 4 A). In an in vitro SRC pep-
tide transphosphorylation assay, recombinant tyrosine-phos-
phorylated TSAd was able to activate LCK kinase activity in 
a dose-dependent fashion from concentrations as meager as 
0.01 μM up to 1.0 μM (although, at 10 μM, the eff  ect of 
TSAd was diminished). However, even at 1.0 μM, the de-
gree of LCK activation was less than that observed after stim-
ulation of wild-type LN T cells with CD3/CD28 antibodies 
(Fig. S1, available at http://www.jem.org/cgi/ content/full/
jem.20051637/DC1). This suggests that, although TSAd is 
required for LCK activation in vivo (Fig. 3, C and D), TSAd 
is not suffi   cient for full LCK activation and that full LCK 
activation in vivo may depend on TSAd cooperation with 
other factors (e.g., CD45).
Using a yeast multihybrid system, we established that 
physical interaction of LCK and TSAd was mediated through 
both LCK SH2 domain recognition of LCK-phosphorylated 
tyrosines in the TSAd COOH region (Y275, Y292, and 
Y317) and SH3 domain recognition of a TSAd COOH re-
gion proline-rich stretch (259RPRPPIPAK267) (Fig. 4 B) (17). 
This is signifi  cant since LCK SH2 domain binding to phos-
phorylated LCK Y505 (located in a short peptide COOH to 
the kinase domain) and LCK SH3 domain binding to an 
LCK proline-rich stretch (located in a linker region be-
tween the LCK SH2 and kinase domains) are both thought 
to restrain the kinase in an inactive conformation (10). There-
fore, by interacting with LCK SH2 and SH3 domains, TSAd 
might relieve LCK from these autoinhibitory mechanisms 
and activate the kinase. To confi  rm the importance of the 
diff  erent TSAd COOH region residues, the eff  ect of their 
mutation upon an ability of TSAd to activate LCK in vitro 
was examined (Fig. 4 C). As shown, mutation of all of the 
three TSAd tyrosine residues to phenylalanine (3Y-F) pro-
foundly reduced the ability of TSAd to activate LCK kinase 
activity. In addition, mutation of three of the proline residues 
(3P-A) in the proline-rich stretch (P262, P263, and P265) to 
alanine reduced the ability of TSAd to activate LCK kinase 
activity, although to a lesser degree than the 3Y-F mutation. 
It is predicted that the SH2 domain–Y505 interaction would 
not directly inhibit kinase activity but indirectly by promot-
ing SH3 domain interaction with the LCK linker region. In 
this regard, one possible explanation for the lesser infl  uence 
of the TSAd 3P-A mutation upon LCK activity could be 
Figure 2.  Impaired LAT phosphorylation and interaction with 
PLC𝗄1 and Grb-2 in TSAd-defi  cient T cells. LN T cells from TSAd 
(+/+) and (−/−) mice were stimulated with optimal concentrations 
of CD3 and CD28 mAb for the indicated times (in min). (A) PLCγ1 acti-
vation was assessed by Western blotting of whole cell lysates using a 
phospho-specifi  c antibody. (B) LAT was immunoprecipitated from 
  lysates. Phosphorylation of immunoprecipitated LAT on Y136 and Y195 
and coimmunoprecipitation of PLCγ1 and Grb-2 was detected by 
  Western blotting using specifi  c antibodies. (C) Activation of ZAP-70 
was   assessed by Western blotting of whole cell lysates using a 
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that the 3P-A mutant would still be capable of disrupting 
the SH2–Y505 interaction and hence, to a degree, the SH3–
linker interaction also. Conversely, even though the TSAd 
3Y-F mutant would still contain the proline stretch, this 
might not have access to the LCK SH3 domain so long as 
the LCK SH2 domain–Y505 interaction remained intact. As 
expected, a TSAd protein containing both types of   mutation 
(3Y-F/3P-A) was unable to activate LCK kinase activity.
We examined if TSAd COOH region tyrosine residues 
and the proline-rich stretch were required for CD3/CD28-
induced activation of LCK in vivo (Fig. 4 D). For this pur-
pose, resting splenic T cells from TSAd (−/−) mice were 
reconstituted with wild-type or 3Y-F/3P-A TSAd. In wild-
type TSAd-reconstituted T cells, activation of LCK in re-
sponse to CD3/CD28 was restored. In contrast, in mutant 
TSAd-reconstituted T cells, activation of LCK was not ap-
parent. These results are consistent with the idea that physical 
interaction of TSAd with the SH2 and SH3 domains of LCK 
is necessary for activation of LCK kinase activity induced 
through CD3/CD28 ligation.
The mechanism by which the TCR induces LCK acti vation 
is only partially understood. A prevailing view is that TCR 
  engagement triggers LCK into open forms and induces their 
  local aggregation, leading to transphosphorylation of Y394 
in the kinase domain and resultant full activation of   enzymatic 
activity (10). How the TCR promotes the open conformation is 
unclear, although the CD45 protein tyrosine phosphatase, 
by   dephosphorylating Y505, is considered to play an impor-
tant role (18). Based upon the fi  ndings here, we   propose an 
updated model of TCR-induced LCK activation. In this model, 
TCR engagement would be envisaged to stimulate an initial 
increase in kinase activity that would be independent of TSAd. 
This would be   possible either through the action of CD45 
and/or the local   aggregation of LCK molecules that preexist 
in open conformations. The initial increase in kinase activity 
would then lead to phosphorylation of TSAd COOH tyro-
sine residues that may expose the COOH region proline-rich 
stretch. As a result, TSAd would have the capability to inter-
act with the LCK SH2 and SH3   domains and, in so doing, 
would have the eff  ect of triggering additional LCK molecules 
(perhaps in concert with CD45) into open and, subsequently, 
fully activated conformations.
Apart from LCK, TSAd has also been described to interact 
with the Tec family PTK, Rlk and Itk, and the mitogen-
  activated protein 3-kinase, MEKK2 (4, 7). Because Tec family 
PTK reside downstream of SRC family PTK in T cells, it is 
probable that their activation is also impaired in TSAd-defi  -
cient T cells and that this contributes to defi  cient induction 
of IL-2 (19). However, whether TSAd directly modulates Tec 
family kinases in T cells is uncertain because physical interac-
tion has hitherto been demonstrated only in yeast hybrid sys-
tems or under conditions of strong overexpression of both 
molecules. With regards to MEKK2,  physical interaction has 
been shown to be necessary for MEKK2 activation in an epi-
thelial cell line (7). However, physical interaction between en-
dogenous molecules in T cells has also yet to be demonstrated. 
Moreover, the notion that TSAd is required for MEKK2 
  activation in T cells is diffi   cult to reconcile with the fi  nding 
that T cells from MEKK2-defi  cient mice produce increased 
quantities of IL-2 in response to TCR stimulation (20).
Figure 3.  LCK activation in TSAd-defi  cient T cells. LN T cells from 
TSAd (+/+) and (−/−) mice were stimulated with optimal concentrations 
of CD3 and CD28 mAb for the indicated times in minutes (1 min in B). 
(A) Whole cell protein phosphorylation was determined by Western blott-
ing using a phosphotyrosine antibody. Also shown is a longer exposure of 
the low molecular weight range of the phosphotyrosine blot to reveal the 
TCRζ chain. (B) LCK was immunoprecipitated from lysates and coim-
munoprecipitated TSAd was detected by Western blotting. (C) Activation 
of LCK was assessed by Western blotting of whole cell lysates using a 
phospho-Y394 LCK antibody. (D) Kinase activity of immunoprecipitated 
LCK was assessed by an ability to self-incorporate 32P in autokinase 
  assays. Separate aliquots from autokinase assays were analyzed by 
  Western blotting using an LCK antibody to check for equivalent 
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In contrast with peripheral T cells, TSAd is not required 
for the activation of LCK in thymocytes despite the fact that 
TSAd is well expressed in thymocytes from the CD4+CD8+ 
double-positive stage (4) (Fig. S2, available at http://www.
jem.org/cgi/content/full/jem.20051637/DC1). This is con-
sistent with the fi  nding that TSAd is not required for either 
positive or negative selection in the thymus as determined 
using non-TCR transgenic and TCR transgenic mice (4, 21) 
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20051637/DC1). The molecular mechanisms responsi-
ble for an uncoupling of TSAd from LCK in thymocytes are 
unclear at present, although this is unlikely to be explained 
by lack of association of the two molecules that can be read-
ily detected in thymocytes (Fig. S2). It is possible that other 
regulatory proteins can compensate for the loss of TSAd in 
thymocytes. Candidates include Unc119, which is expressed 
at low levels in all hematopoietic cells and the recently de-
scribed TSAd-related molecule, ALX, whose expression in 
thymus has been documented previously (22, 23).
In summary, we reveal a novel aspect of the regulation of 
LCK in T cells that involves TSAd. By promoting LCK acti-
vation during TCR triggering, TSAd controls diff  erent 
downstream cytoplasmic signaling events that regulate cyto-
kine synthesis. Together with a proposed nuclear role of 
TSAd, these fi  ndings provide a molecular explanation for the 
role of TSAd in T cell cytokine induction. How cytoplasmic 
and nuclear signaling functions of TSAd are integrated during 
T cell activation remains to be determined.
MATERIALS AND METHODS
Mice. TSAd (+/+) and (–/–) C57BL/6 mice were obtained from Dr. Jeff   
Bluestone (University of California, San Francisco, San Francisco, CA) and 
were bred in our laboratory (4). All mice used in this study were <6 wk of 
age at the time of sacrifi  ce (i.e., before the onset of autoimmune disease in 
TSAd-defi  cient mice).   Extensive phenotypic analysis of lymphoid organs re-
vealed that T cells from TSAd (−/−) mice were normal (compared with 
wild-type mice) at this age and did not show any signs of increased past or 
recent activation (Fig. S3). All experiments were performed in compliance 
with University of Michigan guidelines and were approved by the Univer-
sity Committee on the Use and Care of Animals.
Figure 4.  TSAd activation of LCK kinase activity. (A) LCK was immuno-
precipitated from TSAd-defi  cient LN T cells and tested for its ability to 
transfer 32P to a SRC peptide substrate in the presence of a tyrosine-
phosphorylated His6-Smt3–tagged TSAd fusion protein. (B) Yeast were 
transformed with the indicated TetR-fused LCK SH3-SH2 bait proteins 
and TA-fused TSAd COOH region prey proteins. WT, wild-type bait or prey 
proteins; 3Y-F and 3P-A, Y275F/Y292F/Y317F and P262A/P263A/P265A 
triple mutants of the TSAd COOH region, respectively; W-R, inactivating 
W97R mutant of the LCK SH3 domain; R-K, inactivating R154K mutant of 
the LCK SH2 domain. Yeast were also transformed with the kinase domain 
of LCK fused to LexA to phosphorylate the TSAd COOH region. The LexA 
moiety is irrelevant to the system and the kinase domain fusion protein is 
predicted to diffuse freely within the cell. Growth of yeast on Uracil drop-
out plates was assessed after 48 h of incubation and taken as an indicator 
of bait–prey interaction. Note that mutation of tyrosine residues and the 
proline-rich stretch of the TSAd COOH region are necessary to prevent 
interaction with LCK. Note also that mutation of the SH2 and SH3 domains 
of LCK is necessary to prevent interaction with TSAd when the latter is 
phosphorylated (by LCK). (C) Experiments were conducted as in A using 
the indicated TSAd fusion proteins. SRC-peptide phosphorylation (left) and 
autokinase activity (right) was determined. (D) Splenic T cells from TSAd 
(−/−) mice were transfected with wild-type, 3Y-F/3P-A TSAd, or vector 
alone (None) and stimulated with optimal concentrations of CD3 and CD28 
mAb for 2 min. Phosphorylation of LCK on Y394 was assessed by Western 
blotting of whole cell lysates using a phospho-specifi  c antibody. Blots were 
reprobed with LCK and TSAd antibodies to show equivalent loading of LCK 
and expression of TSAd, respectively. TSAd is observed as a triplet of three 
proteins of very similar molecular weights in these experiments. The spe-
cies of intermediate molecular weight comigrates with a nonspecifi  c band 
that can be identifi  ed in T cells transfected with vector alone.286  TSAD REGULATION OF LCK | Marti et al.
Antibodies. Primary mAb against the following antigens were used: CD3ε 
(145-2C11), CD28 (37.51) (BD Biosciences); Ras (RAS10) (Upstate Bio-
technology); LAT (a gift from W. Zhang, Duke University, Durham, NC); 
LCK (3A5) (Santa Cruz Biotechnology, Inc.); and protein phosphotyrosine 
(PY99) (Santa Cruz Biotechnology, Inc.). Primary rabbit polyclonal anti-
bodies were as follows: ERK, phospho-ERK, JNK, phospho-JNK, PLCγ1, 
phospho-Y783 PLCγ1, phospho-Y195 LAT, ZAP-70 and phospho-Y319 
ZAP-70 (Cell Signaling Technology); p-38α and Grb-2 (Santa Cruz Bio-
technology, Inc.); phospho-Y136 LAT (BD Biosciences); LCK (Upstate 
Biotechnology); and phospho-Y394 LCK (a gift from A. Shaw, Washington 
University, St. Louis, MO). A rabbit polyclonal TSAd antibody was 
  produced by immunization of rabbits with a His6-Smt3–murine TSAd 
  fusion protein.
Protein phosphorylation, coimmunoprecipitation, Ras activation, 
and kinase assays. LN T cells (purifi  ed by negative selection) were coated 
with CD3ε and CD28 mAb (1 μg each/5 × 106 cells) for 20 min at 4°C. 
Secondary cross-linking antibody was added and cells were transferred to 
37°C for varying times before resuspension in lysis buff  er containing 1% 
NP-40 and 0.5% n-Dodecyl-β-D-maltoside. Western blot analyses of pro-
tein phosphorylation in whole cell lysates and coimmunoprecipitation stud-
ies were performed as described using 3 and 50 × 106 T cells per condition, 
respectively (6, 17). To assay Ras activation, lysates of 50 × 106 T cells 
were rotated with GST-Raf-1-RBD–coated agarose beads (Upstate Bio-
technology) for 40 min at 4°C. Beads were washed extensively and any 
bound Ras-GTP was detected by Western blotting. LCK autokinase activity 
and SRC peptide phosphorylation was assessed as described using LCK im-
munoprecipitated from 7 × 106 LN T cells (24). Tyrosine-phosphorylated 
His6-Smt3–murine TSAd fusion protein, produced in TKB1 bacteria (BL21 
that express a tyrosine kinase) (Stratagene), was incorporated into kinase re-
actions from the outset.
Calcium mobilization. Intracellular calcium fl  ux experiments were per-
formed as described previously (25). Fura-2–labeled (Invitrogen) LN T cells 
(107/2 ml) were stimulated by the addition of CD3ε plus CD28 mAb (op-
timal stimulation: 1 μg/ml; suboptimal stimulation: 0.05 μg/ml) and a sec-
ondary cross-linking antibody. Light emission at 510 nM wavelength in 
response to excitation with light of wavelengths of 340 and 380 nM was 
recorded over time in a fl  uorimeter (PerkinElmer).
Yeast-hybrid experiments. The modifi  ed yeast two-bait interaction trap 
system was used to dissect the mechanism of TSAd–LCK interaction (17). 
CXWY2 yeast were transformed with TetR DNA-binding domain-LCK 
SH3-SH2 (residues 56–232) bait proteins, transcription activator (TA)-
TSAd COOH region (residues 192–366), prey proteins, and a LexA DNA-
binding domain-LCK kinase domain (residues 241– 509) fusion protein to 
phosphorylate the TSAd prey. After selection of transformants on LHW 
dropout plates, yeast were plated onto LHWUra dropout plates and growth 
was assessed after 48 h.
TSAd reconstitution. T cells were purifi  ed from spleens of C57BL/6 
TSAd (−/−) mice by negative selection and were transfected with murine 
TSAd or TSAd 3Y-F/3P-A contained in pcDNA3.1 (Invitrogen) or with 
pcDNA3.1 alone using an AMAXA nucleofection device. After 20 h of cul-
ture, cells were stimulated with CD3ε/CD28 mAb and lysed. Activation of 
LCK was determined by Western blotting of whole cell lysates.
Online supplemental material. Fig. S1 compares LCK activation in-
duced by CD3/28 in vivo and recombinant TSAd in vitro. Fig. S2 shows 
normal activation of LCK in TSAd (−/−) thymocytes and LCK associa-
tion with TSAd in TSAd (+/+) thymocytes. Fig. S3 is a fl  ow cytometric 
and histological analysis of lymphoid organs from 6-wk-old TSAd (+/+) 
and TSAd (−/−) mice. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20051637/DC1.
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